Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

February 2012

Another Whistleblower Lawsuit: Why Care?

IN READING THIS ISSUE, YOU MAY LEARN, FOR THE FIRST TIME, how a former CEO of a public lab has filed two whistleblower lawsuits. His most recent qui tam lawsuit names Laboratory Corporation of America as defendant. The earlier qui tam lawsuit was filed against Quest Diagnostics Incorporated. (See pages 3-8.) To my recollection, this …

Another Whistleblower Lawsuit: Why Care? Read More »

To access this post, you must purchase The Dark Report.

‘Pull Through’ Is Key Issue in Lab Whistleblower Suit

CEO SUMMARY: Now comes a whistleblower lawsuit in federal court with the claim that, in the 2007 contract between UnitedHealth Group and Laboratory Corporation of America, LabCorp’s discounted lab test prices were a kickback that violated Medicare law. LabCorp has denied the allegations and says it complies with all laws. Legal experts wonder if the …

‘Pull Through’ Is Key Issue in Lab Whistleblower Suit Read More »

To access this post, you must purchase The Dark Report.

Former Lab CEO Explains Why He Filed Lawsuit

CEO SUMMARY: It may be the first time that a former public laboratory CEO has turned whistleblower. Andrew Baker, formerly Chairman and CEO of Unilab Corporation in the 1990s, filed a qui tam case in federal court last year that centers on the practice of lab companies offering private health plans deeply-discounted lab test pricing …

Former Lab CEO Explains Why He Filed Lawsuit Read More »

To access this post, you must purchase The Dark Report.

HIMSS Says 46% of Hospitals Are at Stage 3 EMR Usage

ADOPTION OF ELECTRONIC MEDICAL RECORD (EMR) SYSTEMS by hospitals is occurring at a steady pace. That’s one recent finding by the Health Information and Management Systems Society (HIMSS). In a statement made on February 17, HIMSS officials said that 46% of the nation’s hospitals had achieved Stage 3 in their use of EMRs. This stage …

HIMSS Says 46% of Hospitals Are at Stage 3 EMR Usage Read More »

To access this post, you must purchase The Dark Report.

Shaw & Adelman Successful Support of Lab Networks Need Hospital Leadership

CEO Summary: In the second installment of our exclusive two- part interview, the executive directors of two regional laboratory networks formed in the 1990s (one in Michigan and one in Washington State) share their assessment of why their respective lab networks have performed strongly over the past two decades. They also identify the reasons why …

Shaw & Adelman Successful Support of Lab Networks Need Hospital Leadership Read More »

To access this post, you must purchase The Dark Report.

MedTox, Cleveland Clinic Labs, Apollo PACS, Dell, British Columbia Health

GENOME SEQUENCING TO BE OFFERED BY NORWAY IN NATIONAL HEALTH PLAN HERE’S A MILESTONE ON THE PATH TO PERSONALIZED MEDICINE. Norway is the first nation to announce that its national health system will incorporate whole genome sequencing. Cancer is the target of Norway’s first genome sequencing program. What sets the Norwegian program apart from gene …

MedTox, Cleveland Clinic Labs, Apollo PACS, Dell, British Columbia Health Read More »

To access this post, you must purchase The Dark Report.

February 20, 2012 “Intelligence: Late Breaking Lab News”

In its effort to change how code stacking is used to bill for certain genetic and molecular tests, Palmetto GBA announced changes to its Molecular Diagnostic Services Program (MolDx). Earlier this month, the Medicare carrier announced that the effective date for claim submissions under MolDx would move from March 1, 2012, to May 1, 2012. …

February 20, 2012 “Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

;